PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Alkermes plc (ALKS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINIE00B56GVS15
CUSIP00B56GVS1
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$4.78B
EPS (TTM)$2.28
PE Ratio12.44
PEG Ratio-1,057.29
Total Revenue (TTM)$1.13B
Gross Profit (TTM)$923.87M
EBITDA (TTM)$240.76M
Year Range$22.01 - $32.88
Target Price$34.92
Short %16.74%
Short Ratio13.88

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: ALKS vs. VOO, ALKS vs. SPY

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Alkermes plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%-5.00%0.00%5.00%10.00%MayJuneJulyAugustSeptemberOctober
9.92%
10.74%
ALKS (Alkermes plc)
Benchmark (^GSPC)

Returns By Period

Alkermes plc had a return of 2.27% year-to-date (YTD) and 1.21% in the last 12 months. Over the past 10 years, Alkermes plc had an annualized return of -3.83%, while the S&P 500 had an annualized return of 11.26%, indicating that Alkermes plc did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date2.27%19.50%
1 month0.89%3.09%
6 months9.92%10.74%
1 year1.21%33.68%
5 years (annualized)8.96%14.10%
10 years (annualized)-3.83%11.26%

Monthly Returns

The table below presents the monthly returns of ALKS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-2.49%9.76%-8.82%-9.35%-4.65%2.99%13.36%4.14%-1.62%2.27%
20239.61%-6.63%5.42%1.28%1.33%8.19%-6.45%-0.31%-4.04%-13.64%-0.21%14.91%6.16%
20229.63%-2.51%5.83%9.65%3.47%-0.20%-14.07%-7.54%-5.66%1.66%9.16%5.45%12.34%
20215.21%-9.29%-1.89%17.83%3.00%8.16%5.51%20.83%-1.34%-1.78%-27.63%6.11%16.59%
2020-14.66%19.70%-30.81%-4.92%19.33%18.64%-7.21%-8.16%0.18%-1.93%12.37%9.26%-2.21%
201911.39%1.22%9.68%-16.91%-28.96%4.64%2.75%-9.41%-7.01%0.10%7.63%-2.95%-30.87%
20184.46%-0.16%1.54%-23.62%6.62%-12.80%6.54%2.26%-5.35%-3.79%-10.75%-19.02%-46.08%
2017-2.64%4.42%3.54%-0.43%-0.84%0.36%-6.14%-6.67%0.12%-4.09%7.24%4.67%-1.53%
2016-59.67%0.81%5.95%16.26%16.75%-6.87%15.46%-12.28%7.45%7.19%12.74%-2.20%-29.98%
201523.38%-2.77%-13.21%-9.18%10.35%5.30%8.83%-14.94%-1.49%22.58%2.00%8.21%35.55%
201419.72%-0.02%-9.41%4.92%-0.97%9.87%-15.04%4.61%-4.16%17.91%8.84%6.43%44.02%
201324.51%-5.81%9.12%29.16%2.09%-8.22%17.09%-5.45%5.89%4.70%14.72%0.69%119.55%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ALKS is 39, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of ALKS is 3939
ALKS (Alkermes plc)
The Sharpe Ratio Rank of ALKS is 4242Sharpe Ratio Rank
The Sortino Ratio Rank of ALKS is 3636Sortino Ratio Rank
The Omega Ratio Rank of ALKS is 3434Omega Ratio Rank
The Calmar Ratio Rank of ALKS is 4141Calmar Ratio Rank
The Martin Ratio Rank of ALKS is 4141Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Alkermes plc (ALKS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ALKS
Sharpe ratio
The chart of Sharpe ratio for ALKS, currently valued at 0.05, compared to the broader market-4.00-2.000.002.000.05
Sortino ratio
The chart of Sortino ratio for ALKS, currently valued at 0.36, compared to the broader market-4.00-2.000.002.004.000.36
Omega ratio
The chart of Omega ratio for ALKS, currently valued at 1.04, compared to the broader market0.501.001.501.04
Calmar ratio
The chart of Calmar ratio for ALKS, currently valued at 0.02, compared to the broader market0.002.004.006.000.02
Martin ratio
The chart of Martin ratio for ALKS, currently valued at 0.11, compared to the broader market-10.000.0010.0020.000.11
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.79, compared to the broader market-4.00-2.000.002.002.79
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.71, compared to the broader market-4.00-2.000.002.004.003.72
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.51, compared to the broader market0.501.001.501.51
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 2.46, compared to the broader market0.002.004.006.002.46
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 16.96, compared to the broader market-10.000.0010.0020.0016.96

Sharpe Ratio

The current Alkermes plc Sharpe ratio is 0.05. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Alkermes plc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00MayJuneJulyAugustSeptemberOctober
0.05
2.79
ALKS (Alkermes plc)
Benchmark (^GSPC)

Dividends

Dividend History


Alkermes plc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%MayJuneJulyAugustSeptemberOctober
-71.07%
-1.09%
ALKS (Alkermes plc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Alkermes plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alkermes plc was 96.15%, occurring on Jul 11, 2002. The portfolio has not yet recovered.

The current Alkermes plc drawdown is 71.07%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.15%Mar 2, 2000591Jul 11, 2002
-92.95%Jan 10, 1992755Jan 4, 1995537Feb 18, 19971292
-64.98%Feb 19, 199748Apr 28, 1997440Jan 26, 1999488
-44.58%Nov 4, 199118Nov 27, 199124Jan 3, 199242
-28.52%Mar 22, 199942May 19, 199957Aug 10, 199999

Volatility

Volatility Chart

The current Alkermes plc volatility is 10.11%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%MayJuneJulyAugustSeptemberOctober
10.11%
3.33%
ALKS (Alkermes plc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alkermes plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Alkermes plc compared to its peers in the Biotechnology industry.


PE Ratio
500.01,000.01,500.02,000.012.4

The chart displays the price to earnings (P/E) ratio for ALKS in comparison to other companies of the Biotechnology industry. Currently, ALKS has a PE value of 12.4. This PE ratio falls in the average range for the industry.

PEG Ratio
-1,000.0-800.0-600.0-400.0-200.00.0-1,057.3

The chart displays the price to earnings to growth (PEG) ratio for ALKS in comparison to other companies of the Biotechnology industry. Currently, ALKS has a PEG value of -1,057.3. This PEG value is considered to be low compared to the rest of the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Alkermes plc.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items